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Summary 
The capsular polysaccharide is the major virulence factor of Streptococcus pneumoniae.  Previously, 
we identified and cloned a region from the S. pneumoniae chromosome specific for the production 
of type 3 capsular polysaccharide. Now, by sequencing the region and characterizing mutations 
genetically and in an in vitro capsule synthesis assay, we have assigned putative functions to the 
products of the type-specific genes. Using DNA from the right end of the region in mapping 
studies, we have obtained further evidence indicating that the capsule genes of each serotype 
are contained in a gene cassette located adjacent to this region. We have cloned the region flanking 
the left end of the cassette from the type 3 chromosome and have found that it is repeated in 
the S. pneumoniae  chromosome. The DNA sequence and hybridization data suggest a model 
for recombination of the capsule gene cassettes that not only describes the replacement of capsule 
genes, but also suggests an explanation for binary capsule type formation, and the creation of 
novel capsule types. 
S 
treptococcus pneumoniae produces a serotype-specific cap- 
sular polysaccharide that is required for virulence. The 
polysaccharide protects the organism from the host's immune 
system and prevents phagocytosis. More than 80 different sero- 
types have been identified (1), and the type of capsule ex- 
pressed may influence virulence (2-4). Griffith's purpose in 
studying pneumococci was to determine if interconversion 
of type occurred in patients infected with more than one sero- 
type and determine if this transformation affected the out- 
come of the infection (5). Today the importance of transfor- 
mation for the organism's potential ability to infect its host 
is still not clear. Transformation could result in an antigenic 
shift, allowing an organism to colonize a previously immune 
host. Epidemiologic studies have suggested that a significant 
amount of genetic exchange does occur in nature, i.e., mul- 
tiple combinations of antigenicaUy variable determinants such 
as capsular serotype, PspA serotype, electrophoretic type, and 
penicillin binding protein type have been observed (6-9). 
Classic experiments demonstrated that genes specific for 
the production of a given capsular polysaccharide are closely 
linked in the chromosome and can be transferred as a unit 
during genetic transformation (5, 10, 11). Except in rare cases, 
transformation to the new type results in loss of the ability 
to express the original polysaccharide (12). These data sug- 
gested  that  the  capsule  genes  might  be  replaced  in  the 
recipient's chromosome through a cassette-type recombina- 
tion mechanism. Biochemical characterization of strains trans- 
formed to new types supported this hypothesis. Strains that 
produced a particular nucleotide sugar as an intermediate in 
capsule synthesis no longer produced the nucleotide sugar 
after being transformed to a new type that did not require 
it (12). These results, though suggestive, did not conclusively 
show exchange of the capsule genes since regulatory models 
could not  be ruled out.  Recently, we demonstrated that 
switching of capsular type by genetic transformation in vitro 
does result in replacement of the type-specific genes (13). How- 
ever, the mechanism of recombination resulting in exchange 
of capsule type has not been fully elucidated, nor is it known 
how the multiple different capsule types have evolved. 
Type 3 capsule synthesis has been characterized biochemi- 
cally and genetically. At least two functions are necessary for 
its production: the synthesis of the precursors UDP-glucose 
(UDP-Glc)  1 and  UDP-glucuronic  acid  (UDP-GlcA),  and 
their polymerization into the polysaccharide. Some 25 dis- 
tinct mutations resulting in a reduction or loss  of capsule 
synthesis were mapped to a single locus thought to encode 
UDP-Glc dehydrogenase (UDP-Glc DH), the enzyme neces- 
sary for conversion of UDP-Glc to UDP-GlcA (14). Charac- 
terization of the nucleotide-sugar pools of several mutants 
revealed a loss of UDP-GlcA. In an in vitro polymerization 
reaction, a partially purified extract from a type 3 strain was 
used to produce type 3 polysaccharide (15).  UDP-Glc and 
UDP-GlcA were the only molecules that served as substrates, 
1  Abbreviations used in this paper: Glc-l-P UT, glucose-l-phosphate  uri- 
dylyltransferase;  GlcNAc,  N-acetyl  glucosamine;  HA, hyaluronic  acid; IPTG, 
isopropyl-~-D-thiogalactoside;  RBS, ribosome  binding site; UDP-G|c  DH, 
UDP-GIc dehydrogenase;  UDP-Glc, UDP-glucose; UDP-GlcA, UDP- 
glucuronic acid. 
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enzyme copurified with the particulate (membrane and cell 
wall)  fraction of cell extracts (16), and Mg  z+ was required 
for activity (17). 
We previously localized the chromosomal region neces- 
sary for type 3 synthesis through mutation and cloning anal- 
yses (13). We have now sequenced this region and have fur- 
ther characterized  the genes and their products. Our results 
provide molecular, genetic, and biochemical evidence for the 
roles of the gene products involved in type 3 capsule biosyn- 
thesis. They also suggest mechanisms for the transfer of cap- 
sule type-specific cassettes and the emergence of new capsule 
types. 
Materials  and Methods 
Bacterial Strains.  The parent S. pneumoniae type 3 strain WU2 
and the type 1, 5, 6B, 8, 9, and 22 S. pneumoniae strains have been 
described (4, 13, 18). Other strains are described in the table and 
figures. Culture conditions for S. pneumoniae and Escherichia coli 
have been described (13, 19). 
DNA Analysis.  Denatured plasmid DNA was sequenced by 
the Sanger dideoxy method using the Sequenase 2.0 kit (US Bio- 
chemicals, Cleveland,  OH). Oligonucleotide primers (Oligos, etc., 
Wilsonville, OK) 5'-GCCACTATCGACTACGCG-Y  and 5'-TCA- 
TTTGATATGCCTCCG-Y, corresponding to bp 308 to 325 and 
445 to 428 of the cloning vectors  pJY4163 and pJY4164 (20), respec- 
tively, were used routinely. Primers internal to the cps locus were 
used as necessary. PCK products were sequenced at least twice, 
from  separate amplification reactions, using  a  PCR  product- 
sequencing kit (US Biochem. Corp., Cleveland,  OH). Greater than 
97% of the sequence was obtained for each strand. Sequences  were 
analyzed using the GCG software programs (21). 
The digoxigenin  labeling and chemiluminescent  detection system 
(Boehringer Mannheim, Indianapolis, IN) was used in Southern 
blotting. All other DNA manipulations were performed as previ- 
ously reported (13). 
In Vitro Polysaccharide  Synthesis.  Type  3 polysaccharide  was syn- 
thesized and quantitated in vitro using a modification of Smith 
et al. (16). Crude extracts containing membranes and cytoplasm 
were prepared from 200 ml of S. pneumoniae cultures harvested at 
an OD~ of 0.25 as described (22), except that cell material was 
concentrated  200-fold, and  all  steps were performed using  a 
thioglycolate  buffer (10 mM sodium thioglycolate, 5 mM MggO4, 
100 mM Tris-HC1, pH 8.3) to stabilize the enzymes (23). Diges- 
tion of cell wall material by mutanolysin was performed in this 
buffer and 20% sucrose. Protoplasts were sonicated  three times for 
15 s at 0~  Polysaccharide synthesis was carried out at 34~  for 
2 h in a 1-ml reaction containing 100 #1 of extract, 5 mM UDP- 
Glc, 5 mM UDP-GlcA (where indicated), and I mM NAD in the 
thioglycolate buffer. The reaction was boiled 1 min then quickly 
cooled to  25~  in  H20.  Following centrifugation for 30 s at 
8160 g, the type 3-specific mAb 16.3 (24) was added in excess to 
the supernatant and incubation was continued at 37~  for 30 min. 
Specific Ag-Ab complexes were measured at 650 nm. Capsule was 
quantitated by comparison with a standard curve prepared using 
purified type 3 polysaccharide  (American Type Culture Collection, 
Rockville, MD) (17). Reactions,  done in triplicate,  were standardized 
to protein content of the crude extract, as determined in duplicate 
using a protein assay kit (Bio Rad Labs., Hercules, CA). 
Expression of Cps3S.  A 2.1-kb Sau3AI-PstI  fragment containing 
the Y end of cps3D and the complete cps3S was cloned into the 
expression vector pKK223-3 (25) to yield pJD424. E. coli TG-1 (26) 
or TG-1 transformants were grown  to exponential phase, and 
isopropyl-B-D-thiogalactoside  (ItffG) was added to a concentration 
of 1 mM to induce expression  from the tac promoter of pKK223-3. 
Chromosome Crawling and PCR.  To isolate the 5' end of cps3D 
and upstream DNA, S. pneumoniae WU2 chromosomal DNA was 
first digested with Ed136 II (an isoschizomer of SacI that results 
in blunt ends) and separated on a 0.6% agarose gel. Purified frag- 
ments from 6 to 7 kb were ligated to a 35-bp XbaI UniAmp adaptor 
(Clontech, Palo Alto, CA). The desired fragment was amplified 
by using a primer for the adaptor and a primer corresponding to 
the predicted active site sequence (bp 1802 to 1781) of cps3D A 
1.8-kb PCK product extending from the active site to the SacI site 
upstream of cps3D (see Fig. 1) was obtained. PCK amplifications 
were performed using AmpliTaq  DNA polymerase  (Perkin-Elmer 
Corp., Norwalk, CT). In a similar manner, the 0.9-kb fragment 
from the cps3D active site to the EcoRV site upstream of cps3D 
was amplified  from a 3.5-kb EcoKV  fragment from the WU2 chro- 
mosome. 
Nomenclature.  The capsule  locus ofS. pneumoniae has been desig- 
nated cps (13). To distinguish  between loci of different  capsular sero- 
types, the locus name will be followed  by the number of the sero- 
type, e.g., type 3 is indicated as cps3. The genes of the type 3 locus 
are named based on expected function (13). 
Results 
We previously described a region of the S. pneumoniae chro- 
mosome that contains genes involved in the production of 
type 3 capsular polysaccharide,  and that is specific to type 
3 strains. An "~l-kb fragment of DNA flanking this region 
and common to apparently all capsular  serotypes was also 
identified (13). A genetic and physical map of the region is 
presented in Fig.  1 A. The DNA and deduced amino acid 
sequences of the region containing the genes cps3D, cps3S, 
cps3U, and upstream flanking DNA were determined in the 
present study, and are presented in Fig.  1/~ 
Cps3D Is Homologous to UDP-glucose Dehydrogenase.  Our 
previous genetic data indicated that we had cloned the 3' end 
of cps3D, the gene encoding UDP-Glc DH (13). The DNA 
sequence and derived amino acid sequence  support this as- 
signment. The amino acid sequence is highly homologous 
(56% identity, 73% similarity) to that of the UDP-Glc DH 
(HasB) from Streptococcus ~ogenes (Fig. 2) (27), and to open 
reading frames from the E. coli and Salmonella  enteritica rfo 
clusters (28). Although not shown biochemically or geneti- 
cally to be UDP-GIc DH, these latter sequences share a high 
degree of homology with HasB and Cps3D. 
The  NH2-terminal  amino  acid  residues  2-29  of CpsD 
have  all  the characteristics  of an NAD-binding  site  (29), 
and this sequence is very homologous to regions from HasB, 
AIgD (the GDP-mannose dehydrogenase of Pseudomonas aeru- 
ginosa [30]), and the potential UDP-Glc DH from E. coli and 
S. enteritica. The homology with AlgD was previously noted 
by Garcfa et al. in the deduced amino acid sequence of the 
S. pneumoniae  gene cap3-1 (31). They suggested that Cap3-1 
was the type 3 UDP-Glc DH. From the EcoRV site to our 
ScaI site (bp 883 to 1377, containing amino acids 1-117), our 
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Sa  SpH  PPv SHEvHXBgPv  XPHHEv  Pv.Pv S.  EvPHBg  S  Sp 
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GA~TCCAATCA~GTGTTTGTA~TTTTTGA~A~GGGT~TCG~TAGAc~ACAGCAAA~GG~CATAGTAGTGA~TCCAG~A~TAAAGcA~CAAAAGGGTTGC~AT~GGT  120 
ATAAAAT~TGTAGAGGG~TAGG~TAGGTGCGTGT~GGTA~G~T~TGTTGAGC~AAAACATC~GTA~GTTAGTTATTGCAAAG~TATAAAAGAGAGAGACGCTAAAAATGG  240 
TAAAAAAGAGTGAGGTTGGCCAAAATGAAGAAGTTCTTTG~GCTT~TCCCAT~GTG~TGC~T~GGT~GAAAAAG~TAGCCAGCAGGTCAATATT~TTTTGGTGCGGTA  360 
ACCAATTCCAATGGCTAGAGCAAT~CG  CT~TCATTATT AAAT~AAT~  GAA~G  TC  CTTT  ~TTAGAATATAGAAA~G~TA~  TTC-AAG  T  T  C  ~G~TACT  GGGTGT  CTT  CT  G  A  600 
T~TAAGT~TT~  GT  CJ~C  ~TC~ARAT~  ~TAAATTGC~GGAA~ GCJ~ATC~T  C  CT  ~TACTA~TA  ~TG  GTAT  TA  C~GTC  ~C  G  TTCGCTATTTTA  T  CTTT~  600 
CTTTAAGC~TGTA~A~CTTTTGC~TAGT~C~GGT~TTGGT~G~GAAAGTATG~GTTA~ATGTG~TTTATCGTGAAGACCA~CAT~C~CTGGATAAACG  720 
AC~T  GCTT  T  TAAC~T~T~TATCGAAAAATGT  GT~ATATTTTC  TAAJ~  T~TGG  TATTTT  CTAAAAAA~CCT  ~GCTA  T  C  G&T  G  CAAAC~CGGTATAT~  C  T  G  TA~  TTTGGAA 640 
R~  -35  -Io 
~T  T  &TTTGGAAACAGAGGTTA  GC*AAAGT~TCAGTT~C  GG~TAT  C  TT  TT  CAAAGC  T~TAC  TAAGGCACAAAAAAAAGTT  T~T  AT  T  C  CCCT  T~CAATA~TAAAATTATTAy2L~ 960 
~S  m~art  ~,pe~ 
~TAAA~ATT~TTTTTAAATAAAGTGAGAATA~T~TG~GAGAAAGA~ACT~TA~AAAATGAAAATTG~CATTGC~GAAGTGGTTATGTAGGTCTGTCTTTAGC~TGCTA  1080 
MKIAIAGSGYVGLSLAVL- 
~T~CTCAG~AT~TG~GTT~TCATT~TGTTATAAAG~T~G~T~AGTC~TAAAC~TAGAAAAT~TCC~TT~G~T~C~TT~GAAATACTTAGTTGAAA~A~G12~ 
LAQHHEVKVI~VIKDKVRSINNRKSPIKDEAIEKYLVEKE- 
~619T~ 
TTG~TT~AA~CTCCTTA~TCCTGCACACGTTTATAAA~cGT~GTATGCTATTATTGCTACTCCGACT~TTAT~TGTA~CTTAAATCAGTTT~TACATCTTCACTTBAA  1320 
LNLEASLDPAHVYKDVETAIZATPTNYDVDLNQFDTSSVE- 
S~al 
~GCTATCA~CTT~ATGG~TAT~TCATACTTGTAc~TCGT~TCA~GTACTATTCCTGAAGGGTATACTAAAG~GTCAGG~A~AGTTT~TACA~ATCGTATTATTTTT144~ 
AAIKTCMEYNDTCTIVIKSTIPEGYTKEVREKFNTDRIIF- 
HJnd~T1 
TCTCCAGAGTTTCTACGTGAATCCAAAGCTTTATA~T~TTTGTATCCATCTAG~TTGTTGTAGG~CT~TTTGGATGATTCTGAGTT~CAAAAAGAGCATGGCAG~TTGCA~T  1560 
SPEFLRESKALYDNLYPSRIVVGTDLDDSELTKRAWQFAD- 
￿9  J0982 
CTACTTAAAGGT~GCTATT~GGAAGAGGTTCC~TACTGGTTGTTGCTTTT~TG~GCAGAGGTTGCAAAATTGTTTAGT~CACTTACTTGG~CTCGCGTAGCTTATTTT~T~66~ 
LLKGGAIKBEVPILVVAPNEAEVAKLFSNTYLATRVAYFN- 
GAGATA~TACATATAGC~GGTAAAAGG~CTT~TCCC~C~TTATT~ATATTGTTTGTTATGATCCTAG~TTG~TCAGACTAT~T~CCCTAGCTTTGGTTACGGAGGGTAT  1000 
EIDTYSEVKGLNPKTIIDIVCYDPRIGSDYNNPSFGYGGy- 
PvuT! 
T~TTACCA~GACAC~GC~TTG~AAGC~GTTTTAGGGATGTTCCTG~AATCTGATTACAGCTGTCCTGC~TCT~TAA~AC~GA~AAGATTATATAGCTGGAGCTATTCTAt920 
CLPXDTKOLKASFRDVPENLITAVVQSNKTRKDYIAGAIL~ 
~A  ~611  A66R~  AA~  TCT Rxl 
GcTAAAC~CCTAGTGTTGTAGGTATTTATAG~TTATGAAATCTCATTCTGATAA~TT~TTCTA~T~CTGTT~GGGAGTTATGG~CGTTTGG&C~TTATGGTAAAGA~TT2~4~ 
AKQPSVVGIYRLIMKSDSDNFRSSAVKGVMERLDNYGKEI~ 
K  c  Ssol 
GTTATTTACG~CCTAcTATTGAGTGTGATACTTTTATGGGATACACAGT~TTA~ATCTTTACATG~TTT~G~TATTTCTGACATTGTT~TAGCCAATCGTATG~CGATGATTTA  2160 
VIYEPTIECDT~MGYRVIKSLOEFKNISDIVVANRMNDDL- 
end  cp$3O  ~s  ~tarc  cps3S  ￿9  JDgE3 
AGGGATAT&C~GAAAAACTCTAT~CACGCG~TTTATTTGGC~GAG~T~GG~A/~T~TTTTTATGTAT~CATTTATTTT~TGTTGTTGGATTTTTTTCAG~TC~TGATTTTCAT22~ 
RDIOEKLYTRDLFGRE*  MYTF~LMLL~FFQN~DFH- 
TTcTTTATGTTGTTTTTTGTCTTTATTCTTATTCGTTGGGCGGTTATATATTTTCATGCT~T~TAT~GTCCTA~A~TT~TACTGT~GTGATGAG~GTTATTTA~TTCTGT~TT  2400 
FFMLFFVFILIRWAVIYFHAVRYKSYSCSV~DEKLFSSV]- 
ATCCcT~TCGTG~TG~C~CTT~TCTTTTTGAAAGTGTACTC~ATAGAATTTcCAGAcATA~CCATC~GAAATTATTGT~GTTATT~C~CCCAA~CGA~CTT~TAAAA~2~ 
IPVVDEPLNLFE$VLNR~SRHKPSEIIVVINGPKNERLVX- 
CTTTGTCATGATTTT~TGAAA~TTAGAAAAT~TAT~CTCC~TTC~TGTTATTAcAcTCCTGTTcCTG~C~GACAAATGCTATCCGCGTTGGGCTG~GCATGTGGATTCG~G  2640 
LCHDFNEKLENNMTPI~CYYTPVPGMRNAIRVGLEHVDSO- 
AGTGATATTACAGTTCTAGTAGATAGTGATACAGTATGGAC~CCTAGAACCTTGAGTGAGTT~CTGAAGCCTTTTGTTTGCGATAAAAA~TAGGT~GG~T~CGAC~CA~TT  27g0 
$DITVLVDSDTVWTPRTLSELLKPFVCDKKIGGVTTRQKI- 
CTT~ACCCTGAGCGT~TCTCGT~C~TGTTTGCT~CTT~TTAGAG~AAATTAGGGCAG~GG~CTATGAAAGc~T~GTGTGACTGGTAAAGTA~GGTGCTTACCTGGTCGAACA  2660 
LDPERNLVTMFANLLEEIRAEGTMKAMSVTGKVGCLPGRT- 
ATTGCTTTTAGAAATATAGTGGA~AGAGTGTATACAAAGTTTATAG~GAuACTTTCAT~GATTTCAT~GG~GTTTCTGATGATAG~GTCTTAcAAATTT~CTTTAAA~GGC  3000 
IAFRNIVERVYTKFIEETFHGFHKEVSDDRSLTNLTLKKG- 
TATAAAACTGTTATGCAGGATACTTCTGTTGTGTATACA~AT~TCCTAC~GTT~GAAAAAGTTCATTAGACAGCAACT~GGTGGGCA~GGTTCTCAGTAT~C~TCTAAA~TG  3120 
YKTVN~DTSVVYTDAPTSWKKFIRQOLRWAEGSQYNNLKM- 
ACTCCTTG~TGATTAGAAATGCCCCTCTTATGTTTTTTATTTATTTTACAGATATGATTTTACCTAT~CTACTTATTAGCTTTGGTGTG~TATATTCCTGTT~AA~TAT~AAATATA  3240 
TPWMIRNAPLMFFIYFTDNILPMLLISFGVNIFLLKILNI- 
ACTACA~TTGTTTATACAGCTTCAT~GTGGGAAATTATTTTATATGTTCTTTTGG~TGATTTTTAGCTTTG~G~GAAACTTTAAAGCTATGTCTAG~TGAAGTGGTATTATGTA  33K0 
TTIVYTASWWEIILYVLLGMIFSFGGRNFKAMSRMKWYyV- 
￿9  J06~7  e~  u~3s 
TTTCTTATTCCTGTTTTTAT~TCGTTTT~GTAT~TTATGTGCCCTATTAGGCTATTAG~ACTTAT~GATGTTCTCATGATTTAGGGTGGGG~TAGGAATTT~CAGAGTGAGAT  3400 
FLIPVFIIVLSIIMCPIRLLGLMRCSDDLGWGTRNLTE* 
AAATAGTAGTGCGTATATAGAGTATTTACTCA~GTATT~TTCATTTTTGAAAA~GAAAAGTGTTTTTT~TGTTAAGAAAG~CTTGAAATATCA~TT~CAC~GCTGGAACAA  3600 
-35  -lO  --- 
TTTTAGCTATCTTGTTTTTCATTATATTAGGGATTATTG~TC~cTTTTGTTTT~GGCTCATT~TcATcTGTAGTGGCTCACTT~AGACGT~GGGTCATATTTT~TGTCAA~A~GT372~ 
...........  ~S  ~tact  cp~3U 
GTT~TT~TCACTTATATTATTTT~TA~/~TAGT~T~T~cTTATGAAA/U~A~.~AAAAGCTcTTATTCCTGCTGCAcGGCTG~CACAC~TTTTTGCCT~CCACT  3040 
NKKVg~AVIPAAGLGTRFLPAT- 
MlndIll  H~ndIll 
AAAG~TTGGCA~AA~AAATGCTTCCAATTGTAGACCGCCCCAC~TTC~TTTTGTC~TTG~G~GCTTT~CGTTCG~GT~TTGA~TATTCT~GTAGTTACTGGAAA~GTAAACGT  39&0 
KALAKRHLPIVD~PTIHFVIEEALRS~IEDILVVTGKSKR- 
TCTATTG~GATT~TTTTGATT~CTTTTG~V~TTG~TAT~TCTTAG~C~GGAJ~GATG~CTTCTT~TCAGTT~CGAATC~CT~ATATTA~t`GTACATTTCGTTCGT  4080 
SIEDYFDSTFEL~YSLRKOCKMELLKSVNESTDIKVHFVR- 
C~AAGTTCACCAC~TGGTCTTGGT~CGCTGTTCTCC~GCGAA~TCTTTTGTTGGTGACGAT~CCTTTGTTGT~TGCTTGGT~TGACCTTATG~T~TCACCGACTC~CTGCT~T~42~ 
QSSPRGLGDAVLQAKSFVG~DPFVVNLGDDLMD~TDSTAV 
~900 
CCTTT~C~C~TT~TGG~TGATT~C~CGC~CAC~G~CTTC~CTATCGC~GT~T~CCTGTTAGATATG~TGTTT~TTCTTAT~TGT~TTTCTCCTA~TTGCJ~AACT  4320 
PLTR~LMDDYNATQASTIAVHPVRYEDVSSYGV~SPRLES- 
AGT~T~GCCTCTATAGTGTTGATGCTTTTGTAGAGAAAcCAAAAC~AAG~GCGCCTAGCCATTTAGCTATTATTC~CA~GTTATCTACTTACTCCT~TT~TT~AT&TTAGAA  4640 
SNGLYSVDAFVEKPKPEgAPSHLAIIGRYLLTP~|FSILE- 
ACCCAAAA~AG~C~AGG~TC~TT~TTGACA~AT~TA~TA~TTG~T~A~A~GTGTT~T~GCGCGTC`AATTTGTGGG~AAACG~Ac~TGTT~T~T~G45~ 
TQKPGAGREIQLTDAIDTLgKT~$VPAREFVGKRYDVGDK- 
TTT~TT~ATGA~CATC~TTGATTA~TCTTC~CATCCTCA~TTAAA~G~TTAAAAAATTAC~TTATT~CACT~GT~GC~TT~GAAGCTA~T~CTGTTC~TCA  4650 
FNFMKTSIDYALOHPOIKs 
end  cp~3U 
AGTG~CACCTATG~TTGTATAGAAAGTTATCAAAAATGGCT~TGTCCCTGATCTTC  4740 
SGHL* 
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Figure  1.  (A) Map of the type 3 
capsule locus. Triangles indicate the 
endpoints  of insertion  mutations: 
filled,  loss  of capsule production; 
open, no apparent effect on capsule 
production.  Restriction  sites: Bg, 
BgllI; Ev, EcoRV; H, HindlII;  P, 
PstI; Pv, Pvull; S, Sacl; Sa, SalI; S/,, 
SphI. (B) DNA sequence of the re- 
gion containing cps3D, cps3S, and 
cps3U,  and  upstream  flanking 
DNA.  Putative  promoters  were 
identified using the FIND program 
and scored as in (52).  A region of 
dyad symmetry upstream of cps3  U 
is overlined. Endpoints of insertion 
mutations shown in A are indicated 
by triangles and are labeled with the 
name of the strain containing  the 
mutation. Point mutations in cps3D 
are labeled with the sequence of the 
mutation and the name of the strain 
containing  the  mutation.  Se- 
quencing of the PvulI-SspI  fragment 
of A66R2 began at bp  1921, thus 
additional mutations  between  the 
PvulI site and this point are possible. 
Selected restriction sites are shown. 
These sequence data are available 
fzom EMBL/C-enBank/DDBJ under 
accession number U15171. Cps3D I M~AI~S~LSI~%'L~RBZVKVIDVIKDKVESINN~SPIKDEAI 50 
Illl:lllllllill:ll[.  ::ll.::l::--[l:.lll  II1./I  I 
HasB 1 b~IA%'AGSG~Cr  50 
51 EKYLVEKELNDEASLDPAHVYKDVEYAIIATPTNYDVDLNQFDTSSIrEAA 100 
I  II  .l:l,:.l.ll.  .11:.1..11111111:  :1  Ill  II.. 
51 EYYLKSKQLSIKATLDSKAAYKEAELVIIATPTNYNSRINYFDTQHVETV  i00 
101  IKTCMEYNDTCTIVIKSTIPEGYTKEVREKFNTDRIIFSPEELRESKALY  150 
I1,.:.  I.  .l::llllll  I:..l:l:ll.lllll[llllllllllll 
I01 IKEVLSI~NSHATLIIKSTIPIGFITEMRQKFQTDRIIFSPEFLRESKALY  150 
151 DNLYPSRIVVGTDLDDSELTK.RAWQFADLLKGGAIKEEVPILWAYNEA  199 
llllilil:l:.: :If. .I  i .If  lil::[ l::ll:i::: . 
151DNLYPSRIIVSCEENDSPKVKADAEKFALLLKSAAKKNNVPVLIMGASEA  200 
200 EVAKLFSNTYLATRVAYFNEIDTYSE%rKGLNPKTIIDIVCYDPRIGSDYN 249 
l..]]l.lliJ] }lllill:lil.l : li-- II:  ::il.lll .If 
201 EAVKLFA~TYLALRVAYFNELDTYAESRKLNSHMIIQGISYDDRIGMHYN  250 
250 NPSFGYG~CI~EDTKQLKASFRDVPENLITAWQSNKTP/<DYIAGAIL,  298 
lllllililillii~lll I.:.::I:.II.I:I ll,.ll.ill .I: 
251NPSF~GGYCLPEDTKQLLANYNNIPQTLIEAIVSSN~SYIAKQIIN 300 
299 .....  AKQPSWGIYRLIMKSDSDNFRSSAVKGVMERLDNYGKEIVIYEP  343 
.....  II1:111;111:11111,11:1:1::  I.,  :  .1:11 
301 VLKEQESPVKVVGVYRLIMKSNSDNFRESAIKDVIDILKSKDIKIIIYEP  350 
344 TIECDTFMGYRV.IKSLDEFKNISDIWANP/MNDDLRDIQEKLYTRDLFG 392 
::  .  : .i  :,.l::ii- .:l:i.il :::l.l:.:l:i.ll:l{ 
351MLNKLESEDQSVLVNDLENFKKQANIIVTNRYDNELQDVKNKVYSRDIFG  400 
393 ~*  395 
401RD* 402 
as an attenuator ofcps3U expression.  The cps3U open reading 
frame, 918 bp in length, is transcribed in the same direction 
as cps3D and ct~s3S, and is predicted  to encode a protein of 
34 kD. 
Cps3S  Is  Homologous to  Polysaccharide Synthases.  The 
predicted  Cps3S protein has significant homology  to poly- 
saccharide synthases, including HasA, the hyaluronic acid (HA) 
synthase from S. Fyogenes (23% identity,  50% similarity) (34, 
35), and NodC from Rhizobium meliloti (21% identity, 47% 
similarity)  (Fig. 3). HA and the pneumococcal type 3 cap- 
sule are composed of fl(1-4)-linked  repeating disaccharide units 
containing GlcA. HA consists of alternating N-acetyl glucos- 
amine (GlcNAc) and GlcA residues. Both contain fl(1-3) and 
B(1-4) linkages,  however the linkage to GlcA is/~(1-4) in HA 
but/~(1-3) in type 3 capsule  (36). NodC is necessary for the 
Figure  2.  Homology of the Cps3D deduced amino acid sequence with 
HasB.  The NAD-binding region  (residues 2  to  29)  and the active  site 
(residues 251 to 263) are indicated in bold. An asterisk marks the essential  eps3s 
FBFI5 
Cystein@ of the active site.  HasA 
Node 
Cps3S  sequence is in complete agreement with theirs. However, no  rBrz5 
other homology was seen, suggesting that these investigators  ~asA  Node 
had cloned only the  5' end of the gene. 
The Cps3D sequence at residues 251-263 is consistent with 
Cps3S  this being the active site of the enzyme. This region is iden-  rBrls 
tical  to that of HasB  (Fig.  2) and  the putative E. coli and  ,,,A  NodC 
S. enteritica enzymes. The homology of the active site region 
of HasB with that of bovine UDP-Glc DH and AlgD  has 
Cps3S  been described  (27).  The cysteine  at residue  259 of Cps3D  mr15 
contains the essential  thiol group of the reactive  site  (32).  .~,A  Node 
The predicted size of Cps3D (45 kD) is also similar  to that 
of the E. coli enzymes  (47 kD)  (33). 
Cps3S  Sequences ofcps3S and cpsU.  The region  downstream  of  rBr15 
cps3D  contains a second gene, cps3S, that is required for type  Hasa  NodC 
3 capsule  synthesis (13). A  1,248-bp open-reading frame is 
transcribed in the same direction as cps3D and is in the same 
Cps3S  reading frame. This direction is in agreement with that pre-  rsrls 
viously determined using cat insertions (13). Only 15 bp sep-  NodCHaSA 
arate a potential start codon for Cps3S from the stop codon 
of Cps3D. The sequence AGGGGjust upstream of the puta- 
Cps3S  tive start codon (Fig.  1 B ) may serve as a ribosome binding  rSrlS 
site (RBS), or due to the close proximity of cps3D, no RBS  ,ssA  Node 
may be necessary.  The predicted Cps3S is 48 kD in size,  if 
the first start codon at bp 1 (bp 2227 in Fig.  1 B) is used. 
Other potential start codons are located at bp  + 19 (2245)  rBrlsCps3s 
HasA  and + 61 (2287), however neither of these are positioned near  Noac 
a RBS. 
A short region of dyad symmetry was detected downstream 
Cps3S  of cps3S at bp 3718-3738.  The scores  for primary and sec-  rBrxs 
ondary structure ~  =  3.95, s  =  22; GCG TERMINATOR  HasA 
Node 
program) suggest that this region could function as a weak 
rho-independent terminator.  However, this sequence is 241 
bp past the Cps3S stop codon and closer to the start of Cps3U. 
A  potential cps3U promoter was detected upstream  of the 
region of dyad symmetry,  suggesting the structure could serve 
1 
MYTFILMLLD  FFQNHDFHFF  MLFF  ....  VF 
.....  MELFP  I  ....  QILFL  VVLMNRYILG 
.....  MYLFG  ...TSTVGIY  GVILITYLVI 
.....  MYLLD  TTSTAAISIY  ALLLTAYRSM 
.....  M-L  ........  i--y  --II--Y--- 
51 
SVSDEKLFSS  VIIPVVDEPL  NLFESVLNRI 
.....  TV..A  IIIPLFNEGE  GIYHA.IRSL 
KPHDYKV..A  AVIPSYNEDA  ESLLETLKSV 
RPLP.AV..D  VIVPSFNEDP  GILSACLASI 
......  V---  vIIP-fNE  ....  I---L-Si 
101 
ERLVKLCHDF  NEKLENNMTP  IQCYYTPV.P 
DDSYVWALKAAEQHP  ....  N  VMVMRNPENM 
TDAIQLIEEY  VNREVDICRN  VIVHRSLVNK 
R~I~VRAF  YS~PRFSFI  LLPE  .... 
-d-i  .....  f  ..........  v  .......  N- 
151 
VLVDSDTVWT  PRTLSELLKP  FVCDKKIGGV 
VSVDSDVIVD  RGAVRQLVRR  FL.HPRIAAV 
LTVDSDTYIY  PNALEELLKS  FN.DETVYAA 
LNVDSDSTIA  FDWSKLASK  MR.DPEVGAV 
--VDSD--I  .......  L---  F--D  ....  AV 
201 
LEEIRAEGTM  KAMSVTGKVG  CLPGRTIAF. 
KFHFAQEWLK  DLERGFRSVM  CLSGCLTAYR 
RYDNAFGVER  AAQSLTGNIL  VCSGPLSIYR 
EYWLACNEER  AAQSRFGAVM  CCCGPCAMYR 
-y--A  ......  A-S--G-Vm  C--G  ....  YR 
251 
KEVSDDRSLT  NLTLKKGYKT  VMQDTSVVYT 
IKYGEDRFLT  RQIIKAGYET  IYTTAAVCFT 
VSIGDDRCLT  NYAIDLG.RT  VYQSTARCDT 
SDFGEDRHLT  II24LKAGFRT EYVPDAIVAT 
--fGeDR-LT  ....  K-Gy-T  vY---Av--T 
301 
QYNNLKMTPW  MIRNAPLMFF  IYFTDMILPM 
LVDMLGGLSH  AWRLHPVVAV  ....  HYVSQF 
FRESIISVKK  ILS.NPIVAL  ....  WTIFEV 
FRDTFLALPL  LRGLSPFLAF  DAVGQNIGQL 
f-d-i  ..........  P--A  .......  I--- 
351 
VYTASWWEII  LYVLLGMIFS 
FWDILAMHVL  TVGIMGFIYR 
LDLIKLFAFL  SI.I..FIVA 
WWTILIIACM  TI.IRCSVVA 
-w-I  .....  1  -i-I---I-- 
401 
MCPIRLLGLM  RCSDDLGWGT 
FSPL...ALL  TLDSG.SWET 
LQPLKLYSLC  TIKNT.EWGT 
ILPLKAYALC  TLSNS.DWLS 
--PL  ....  L- T  ......  W-T 
FGGRNFKAMS 
WETRHLPDDQ 
L.  CRNVHYMV 
LHARQLRFL. 
1--R-l--m- 
50 
ILIRWAVIYF  HAVRYKSYSC 
PLMRRVRGDQ  FDATNDAYEP 
KL  .......  G  LSFLYEPFKG 
QVLYAR91  DG PAVAAEPVET 
-L  .............  e-y-- 
100 
SRHK...PSE  IIWINGPKN 
LLQDYPPDKL  SIVVVDDCSK 
LAQTYPLS.  E  IYIVDDGSSN 
ADQDYPGELR  VYVVDDGSRN 
--Q-YP  ....  i-VV-DG--N 
150 
GKRNAIRVGL  EHVDSQSDIT 
GKRKGINRGV  RA..TQSEII 
GKRHAQAWAF  ER. .SDADVF 
GKRKAQIAAI  GQ. .SSGDLV 
GKR-A  .........  S--Di- 
200 
TTRQKILDPE  RNLVTMFANL 
GGRTYVTNRH  QNWMTRMIEI 
TGHLNARNRQ  TNLLTRLTDI 
MGQLTASNSG  DTWLTKLIDM 
-G  .....  N--  -N-IT-I-d- 
250 
RN  IVERVYTK  FIEETFMGFH 
RHVLEELEP  I  LEARSIAGVA 
REVI  IPNLER  YKNQTFLGLP 
RSALASLLDQ  YETQLFRGKP 
R-v  .......  y---tF-G-- 
300 
DAPTSWKKFI  RQQLRWAEGS 
ATPANIAGYF  AQQLRWRRSN 
DVPFQLKSYL  KQQNRWNKSF 
VVPDTLKPYL  RQQLRWARST 
--P---K-Y  1  -QQLRW--S- 
35O 
LLISFGVNIF  LLKILNITTI 
GLLLSYPWI  VHNILTG..  E 
VMFMMLIVAI  GNLLFNQAIQ 
LLALSVVTGL  AHLIMTATVP 
-L-I  .........  Ii  ..... 
4OO 
R/~YYVFLI  P~/FIIVLSI  I 
R~GLSFLPM  AIAMMP  I  T  Y~.L 
KHPA.  SFLLS  PLYGILHLFV 
.....  GFV..  .  LHTPINLFL 
......  F1  --  -L---I  .... 
RNLTE*  ........................ 
RGVPRECGHT  GPQRHFPHAS  PAAEGLST*. 
RKKVTIFK* ..................... 
RYSAPEVPVS  GGKQTPIQTS  GRVTPDCTCS 
R  ............................. 
Figure  3.  Bacterial polysaccharide synthases. The alignment was per- 
formed  using  PILEUP.  The  consensus  sequence  was  prepared  using 
PRETTY and a plurality of 3/4. Lower case letters indicate that the con- 
sensus amino acid is representative of a class. 
976  S. pneumoniae  Capsule  Gene  Cassette synthesis of nodulation factor, a substituted  oligosaccharide 
consisting of 8(1-4) linked GlcNAc residues (37). It has been 
noted that HasA and NodC are homologous to polysaccha- 
ride  synthases,  including FBF15 of Stigmatella aurantiaca, 
pDG42 of Xenopus laeveis, and chitin synthases from both 
Saccharomyces cerevisiae and Candida albicans (34, 35, 38, 39). 
Cps3S is also homologous to these proteins. The results sug- 
gest that Cps3S is the type 3 capsular polysaccharide  synthase. 
Four hydrophobic stretches identified in Cps3S are found 
in all four bacterial synthases. As indicated for NodC, these 
regions may span the cell membrane (40, 41). Earlier studies 
indicated that the type 3 synthesizing activity also has a mem- 
brane location (16). The last hydrophobic stretch in Cps3S 
may be required for function since the insertion in JD897 
which eliminated this region (the last 45 amino acids of the 
protein) resulted in loss of capsule production (Fig 1 B). High 
level expression of Cps3S in E. coli was, like that of NodC, 
lethal  to the host (data not shown). 
Cps3U Is Homologous to Glucose-l-phosphate Uridylyltrans- 
ferases.  The amino acid sequence of Cps3U has a high de- 
gree of homology with glucose-l-phosphate  uridylyhrans- 
ferases (Glc-I-P  UT)  from several other bacterial  species, 
including GtaB  from Bacillus subtilis (55%  identity, 73% 
similarity) (Fig. 4 A). The active sites of bacterial GIc-I-P 
UT have not been characterized, however the active site in 
the enzyme from potato tuber has 5 lysine residues (42). One 
of these residues is important for function, and a second is 
absolutely required (43). Cps3U contains 24 lysines, six of 
which are conserved among the six bacterial Glc-l-P UT in 
the database (Fig. 4 A). Only one region from Cps3U con- 
taining a conserved lysine can be aligned well with the potato 
A 
Cps3U  i MKICVKKAVIPAAGLGTRFLPATKALAKEMLPIVDRPTIHFVIEEALRSGI  50 
ilLl:il:lllllLlililillil::ilLlllli:lil:::ii11:  .ll 
GtaB  i MKKVRKAIIPAAGLGTRFLPATKAMPKEMLPIVDKPTIQYIIEEAVEAGI  50 
51 EDILVVTGKSKRSIEDYFDSTFELEYSLRKQGKMELLKSVNESTDI.KVH  99 
Lll::lillLll.lll.li  .  III  -I  ..II  III..I .... ::  .:I 
51 EDIIIVTGKSKRAIEDHFDYSPELERNLEEKGKTELLEKVKKASNLADIH  100 
i00 FVRQSSPRGLGDAVLQAKSFVGDDPFVVMLGDDLMDITDSTAVPLTRQLM  149 
::ll..l:lll. II:  l:.l:ll:li-l:llll:::  ...I  IIII 
101  YIRQKEPKGLGHAVWCARNFIGDEPFAVLLGDDIVQ ....  AETPGLRQLM  146 
150 DDYNATQASTIAVMPVRYEDVSSYGVISPRLESSNGLYSVDAFVEKPKPE  199 
L:I:  I  .i.l:l  .i.  l:.  .II:I.I  I.I..  I  i..Illll..: 
147 DEYEKTLSSIIGVQQVPEEETHRYGIIDP.LTSEGRRYQVKNFVEKPPKG  195 
200 EAPSHLAIIGRYLLTPEIFSILETQKPGAGNEIQLTDAIDTLNKTQSVFA  249 
￿9  lll:llL:III::lllil  .ll.l..lil.lllliliL:.ll..l.lll 
196 TAPSNLAILGRYVFTPEIFMYLEEQQVGAGGEIQLTDAIQKLNEIQRVFA  245 
250 REFVGKRYDVGDKFNFMKTSIDYALQHPQIKESLKNYVIALGKQLEKLDD  299 
:i  iIl1111:1:.i:.l-:::l:l..::::  I  ::  :I  ..  i 
246  YDFEGKRYDVGEKLGFITTTLEFAMQDKELRDQLVPFMEGLLNKEEI  .  292 
300  C$SSGHL* 
B 
Cps3U  16 TRFLPATKA  24 
:llli.  II 
UDPGP  361  SRFLPV.KA 368 
Figure 4.  (A) GAP comparison  of Cps3U with GtaB. The six lysines 
conserved  among  the bacterial  Glc-I-P  UT are indicated  in bold. (B) Align- 
ment of a region  of Cps3U with the region  from  the potato tuber UDP- 
Glc pyrophosphorylase  (Glc-l-P UT) required  for enzyme  function. 
tuber enzyme sequence. It is homologous to the region con- 
taining the required lysine (Fig. 4 B). 
Mutations Affecting Type 3 Capsular Polysaccharide Produc- 
tion.  Two mutations resulting in the capsule-negative  pheno- 
type were previously mapped to cps3D (13). To determine 
the nature of these mutations, the regions were amplified  from 
the chromosomes of the mutant strains and sequenced. Each 
mutant 019611 and JD619) contained a single base pair trans- 
version resulting  in a premature stop codon (Fig. 1 B). 
We also identified three mutations upstream of the JD611 
and JD619 mutations, near a site where a mutation appar- 
ently affecting type 3 capsule polymerization had previously 
been mapped (13, 14). These mutants produced capsular ma- 
terial that was detectable in cell lysates, but the cells could 
not be agglutinated with type 3-specific antisera, and they 
produced non-mucoid colonies. We tentatively identified the 
locus containing these mutations as cpsB, and, based on the 
phenotypes  and map positions,  suggested that cpsB might 
encode a polysaccharide polymerase (i.e., be cpsP) (13). To 
better localize the mutations, we amplified fragments from 
the parent type 3 chromosome that contained either the 5' 
end of the cps3D coding sequence (bp 1027-1802), the pro- 
moter and the 5' end of cps3D (bp 885-1802), or the 5' end 
of cps3D plus '~1 kb of upstream DNA (bp 1-1802). Each 
of the fragments was used to transform the capsule-deficient 
mutants JD614 and JD692. JD692  was transformed to en- 
capsulation using the 5' end coding sequence, whereas JD614 
was not. JD614 was restored by the fragment containing the 
5' end plus 141 bp of upstream DNA, including the pro- 
moter. Both mutants were restored by the 1.8-kb fragment 
containing the 5' end of cps3D and upstream DNA, and nei- 
ther was restored with a fragment containing the 3' end of 
cps3D (bp 1759-2385, data not shown). Thus, these upstream 
mutations are not located in a separate gene but are in either 
the cps3D structural gene or its promoter.  Since some cap- 
sule material is produced by these mutants, a mutation within 
the coding region (as in JD692)  must be a missense muta- 
tion or an in-frame deletion or insertion that reduces the ac- 
tivity of the enzyme. The mutation in JD614 may be in the 
promoter, and thus, a promoter down mutation, or it may 
be in the structural gene but too close to the beginning of 
the gene for recombination and repair to occur with the frag- 
ment used. 
Two other mutations in cps3D resulting in reduced amounts 
of type 3 capsule were restored to normal encapsulation with 
the 250-bp PvulI-SspI fragment from the parent strain (13). 
Amplification  and sequencing of this same fragment from 
the mutant strains A66R2 and Rxl showed that each con- 
tained a missense mutation in the cps3D coding sequence 
(Fig. 1 B). 
Use of fragments subcloned from the cps3DSU region to 
direct insertion-duplication  mutations in the parent type 3 
chromosome (13) resulted in several mutants that produced 
no detectable  capsule  and exhibited the extremely rough pheno- 
type described by Taylor (44). DNA sequencing revealed  that 
the mutations are in cps3S (Fig. 1). The lack of capsule in 
these mutants must be due to loss ofcps3S expression, rather 
977  Dillard  et al. than to a polar effect on downstream genes, since insertions 
within cps3U or cps3M had no apparent effect on capsule 
production, as judged by growth on blood agar medium. 
cps3S and cps3D Are  Transcribed  as an Operon.  Sequence 
analysis revealed no potential promoter sequences in the re- 
gion upstream ofcps3S (Fig. 1 B). The phenotypes of several 
insertion-duplication mutants also suggest that no promoter 
is located in the 3' end ofcps3D and that cps3S is transcribed 
from the cps3D promoter. The sites of these insertions are 
shown in Fig.  1 and their structures are illustrated in Fig. 
5.  Insertion of the plasmids results in a duplication of the 
cloned fragment. Therefore, mutant strains  such as JD908, 
in which the duplicated fragment contains both the 5' end 
of cps3S and the 3' end of cps3D, have a full-length copy of 
cps3S downstream of the plasmid insertion. In addition, the 
full-length copy is contiguous to the 3' end ofcps3D There- 
fore, if cps3S had its own promoter, or if one were located 
in the 3' end of cps3D, these insertions should not result in 
loss of cps3S expression.  However, four such insertions have 
been made in the WU2 chromosome 019846, JD897, JD898, 
and JDg08),  and even with a duplication of 450 bp of the 
3' end of cps3D, a loss of capsule production was observed. 
Two internal insertions in cps3D also eliminated capsule 
production (Fig.  5 A). However, since cps3D and cps3S are 
transcribed as an operon, this result does not prove that cps3D 
is required for capsule  synthesis.  That fact is demonstrated 
by the lack of capsule production seen in strains containing 
non-polar point mutations in cps3D (see below). 
In Vitro Polymerization Assay.  It is not possible  to per- 
form the standard UDP-GIc DH assay on extracts of S. pneu- 
moniae due to the presence ofa NADH oxidase, that copurifies 
with the enzyme (23, 45).  Therefore, the ability of the mu- 
tants to synthesize type 3 capsule was examined in an in vitro 
polymerization assay. MutantsJD611 andJD619, which con- 
tain stop mutations in cps3D, produce no detectable capsular 
material (13). However, both  synthesized high molecular 
weight type 3 polysaccharide in vitro when provided with 
UDP-Glc and UDP-GlcA (Table 1). No capsule was produced 
when UDP-GIcA was omitted from the reaction. These results 
support the conclusion that Cps3D is the UDP-Glc DH, and 
confirm that stop mutations in cps3D are not polar on cps3S. 
Mutants containing insertions in cps3S 0D902), or between 
the full-length copies ofcps3D and cps3S (JD908, JD897) were 
unable to synthesize significant amounts of  capsule even with 
Figure  5.  Location  of insertion  mutations  in the type  3-specific  region. (A) Schematic  illustration  of the insertions.  The schematic  was derived  from 
Southern blot analysis such as that shown in B and C. Restriction sites: F, Fspl; H, Hindlll; K, KpnI; Ms, MscI; P, PstI; Pv, PvulI; X, XbaI. (B) 
Ethidium bromide-stained  agarose  gel of chromosomal  DNA from insertion  mutants  digested  with MscI/Fspl for JD982, MscI/Sall for JD983, and 
MscI/KpnI for JD908, JD902, and JD900. (C) Southern blot of gel in part B probed with the vector pJY4164. Increasing  distance from the Mscl 
site to the end of the vector is demonstrated  by the increase in size of the upper band. The faint band in the JD982 lane is likely a result of partial 
digestion. The 4.7- and 4.8-kb bands in JD982 and JD908, respectively,  indicate that these mutants contain a duplication of the inserted plasmid. 
The vector is homologous to the 1.6-kb fragment  of the molecular size standards, M. 
978  S. pneumoniae  Capsule Gene Cassette Table  1.  In Vitro Capsule Synthesis Assay 
Cps  CPS 
Strain  phenotype*  UDP-GlcAS  (#g/nag protein) 
JD611  Cps3D-S §  +  9.8  _+  0.6 
-  0.9  _+  0.2 
JD619  Cps3D-S +  +  5.7  _+  0.3 
-  0.2  _+  0.1 
JD614  Cps3D*S*  NA  Ij  5.4  _+ 0.4 (to)  I 
+  5.9  _+  0.5 (0.5)  I 
JD692  Cps3D*S*  NA  4.8  _+ 0.3 (to) 
+  7.0  _+  1.0 (2.2) 
JD902  Cps3D§ -  +  1.7  _+  0.3 
JD908  Cps3D+S  -  +  1.5  _+  0.1 
JD897  Cps3D+S  -  +  1.1  _+  0.1 
WU2  Cps3D§  §  NA  3.8  _+  0.2 (to) 
+  16.6  _+  0.3 (12.8) 
-  16.3  +  0.8 
D39"*  Cps2 +  +  0.5  +  0.3 
* Capsule phenotypes are based on the cps3D and cps3S genotypes. 
~ Indicates either a missense or in-frame  deletion or insertion in cps3D 
that apparently  also affects  cps3S. -  indicates  either a stop or insertion 
mutation (see Fig. 1 B and 5 A for locations of mutations). 
S  The presence or absence of UDP-GlcA in the reaction is indicated  by 
a  +  or-. 
II NA, not applicable. 
I For strains that produce capsule in vivo, the amount of polysaccharide 
present at the start of the assay (to) is given, and the amount of poly- 
saccharide produced during the assay is indicated  in parentheses. 
"* D39 is a type 2 strain and thus produces no type 3 capsule. 
both precursors  present. These results emphasize the role of 
Cps3S in capsule synthesis and support the conclusion that 
cps3D and cps3S are transcribed as an operon. 
The capsule-deficient  mutants JD614 and JD692 synthe- 
sized only small amounts of additional polysaccharide in the 
in vitro assay. This result is somewhat surprising  since J'D692, 
which contains a missense mutation in the cps3D coding re- 
gion, should still make a functional Cps3S  (i.e.,  the cps3D 
mutation must not be polar since intact cells synthesize some 
polysaccharide).  The result may suggest that the defective 
UDP-Glc DH interferes with the ability to synthesize normal 
polysaccharide. Alternatively,  the stability of the cps3DS tran- 
script may be altered by the mutation, resulting in a reduced 
amount of Cps3S. 
Biochemical  Pathway.  Based on genetic analysis, amino acid 
homologies, biochemical and immunochemical characteriza- 
tion of mutants, and previous biochemical analyses (12, 13, 
15-17), we propose a pathway for the biosynthesis of type 3 
capsular polysaccharide (Fig. 6). The last of the type 3-specific 
genes, cps3M, is homologous to phosphoglucomutases from 
several bacterial species and is described in a forthcoming pub- 
lication (Caimano, M., J. P. Dillard, and J. Yother,  manu- 
script  in preparation). 
GIc-6-P 
phosphoglucomutase  Cps3M 
Glc-l-P 
UTP ~  glucose-l-phosphate 
uridylyltransferase  Cps3U 
UDP-GIc + PPi 
NAD+~  '  UDPG  dehydrogenase  Cps3D 
NADH  "- 
UDP-GlcA 
UDP-glc ~l  type 3 capsular 
polysaccharide  synthase  Cps3S 
(-GlcA--Glc-)  n 
Figure 6.  Biosynthetic  pathway  for type  3 capsular  polysaccharide.  Func- 
tions of proteins encoded  by the type 3-specific genes are shown. Addi- 
tional functions  may be necessary for capsule transport or attachment. 
Mapping Other Capsule Types.  We previously showed that 
a 1.2-kb SacI-HindlII fragment flanking the type 3 capsule 
locus contains sequences common to apparently all capsule 
types (13). Sequence analysis showed that the fragment con- 
tained the 3' end of cps3M and the 5' half of a gene with 
50% identity to the S. pneumoniae amiA.  The amiA-like se- 
quence has recently also been identified by Pearce et al. and 
named expl  (46), and subsequently renamed plpA (47). Fur- 
ther Southern hybridizations showed that the non-type-specific 
homologous DNA in the 1.2-kb  SacI-HindlII fragment is 
plpA  (data not shown). 
The homologous fragment is closely linked not only to 
the type 3-specific capsule genes, but also to the type-specific 
genes of types 2,  5,  and 6B (reference  13 and our unpub- 
lished data). Mapping studies using this fragment showed 
that, as in type 3, it is directly adjacent to the type-specific 
genes of other serotypes. The chromosome maps of the cap- 
sule regions in strains of types 2, 3, and 6B are highly con- 
served for at least 4 kb to the right of plpA  (Fig.  7).  The 
type 3 strain differs slightly in this region due to a deletion 
of the 5' end of plpA.  The sites located to the left of plpA 
are divergent among the capsule  types, further suggesting 
that this region contains the type-specific  genes in all three 
capsule  types. 
The Region Upstream of the Type 3-specific Genes Is Common 
to All Capsule Types and Is Repeated in the Pneumococcal  Chro- 
mosome. To isolate DNA 5' of the biosynthetic genes, a 1.8- 
kb fragment extending from the upstream SacI site to the 
cps3D active site was amplified from the type 3 WU2 chro- 
mosome. When this fragment was used to probe HindlII- 
digested chromosomal DNA from seven S. pneumoniae sero- 
types, multiple bands were detected in all strains (Fig.  8). 
When  chromosomal DNAs  of types  2,  3,  and 6B  were 
digested with PstI, PvulI, or SacI/HindlII, and probed with 
the cloned 610-bp SacI-HindlII fragment upstream of cps3D 
(Fig. 1), 4-10 bands were detected in each (data not shown). 
Transformation experiments were performed to examine 
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the probe is shown below the maps. Restriction  sites are Bg, BgllI; F, FspI; H, HindlII; S, SalI; Sac, SacI; Sp, Sphl. (B) Ethidium  bromide-stained 
agarose gel and (C) Southern  blot showing chromosomal  DNA from strains of types 2, 3, and 6B probed with pJD377. Faint bands in addition 
to the band of interest may be due to the detection of fragments containing  the arniA-like genes that have homology  to plpA. 
linkage of the upstream region to the type-specific genes. A 
plasmid (pJD392) containing the 610 bp SacI-HindIII frag- 
ment was introduced into the chromosome of the type 3 strain. 
The insert, located in the 2.2-kb HindIII fragment adjacent 
to the type 3-specific genes, did not affect capsule produc- 
tion.  When  the  resulting  strain  was  used  to  transform 
recipients  of  types  2  and  6B,  greater  than  95%  of the 
erythromycin-resistant  isolates expressed type 3 capsule. How- 
ever, when pJD392 was transformed into strains of types 2 
and 6B, the plasmid inserted into an 8-kb HindlII fragment, 
and the type-specific genes could not be moved to strains of 
heterologous types (i.e.,  2, 3, or 6B) by transformation and 
selection for linkage to the erythromycin marker in the in- 
sertions. 
Discussion 
Based on genetic, molecular, and biochemical data we have 
assigned putative functions to the type 3-specific genes. Two 
of the genes, cps3D and cps3S, are required for capsule syn- 
thesis.  Our previous genetic data, along with the sequence 
and biochemical analyses reported here, provide substantial 
evidence that cps3D encodes UDP-Glc DH. Cps3D is highly 
homologous to HasB,  and contains sequences  homologous 
to the active and the NAD-binding sites in HasB and other 
known UDP-Glc DH. Extracts from Cps3D mutants could 
synthesize type 3 capsule in vitro if supplied with UDP-GlcA, 
i.e., they lacked the ability to convert UDpoGlc to UDP-GlcA 
and thus lack UDP-Glc DH  activity. 
Cps3S  is new member of a family of polysaccharide syn- 
thases. All of these synthases, for which the structures of the 
polysaccharides are known, produce 3(1-4)  linked polysac- 
charides.  Thus, Cps3S  may form the 3  (1-4) linkage in the 
type 3 disaccharide cellobiuronic acid (GlcA 311-4] Glc), and 
a second enzyme may create the ~(1-3) linkages required to 
polymerize the disaccharides into full length polysaccharide. 
However, HasA creates both linkages in the production of 
HA capsule (34),  and is sufficient for HA synthesis in heter- 
ologous bacteria,  given the nucleotide sugars  (48).  There- 
fore,  Cps3S,  like HasA,  may synthesize the polysaccharide 
by monomer addition. 
Neither cps3U nor ClOs3M  appears  to be required for type 
3 synthesis.  Cps3M and Cps3U should function to convert 
Glc-6-P into Glc-I-P,  and Glc-l-P into UDP-Glc, respectively 
(Fig.  6).  Since UDP-Glc is necessary for the production of 
essential  cell constituents, including teichoic acid and lipo- 
teichoic acid (12), the products of other genes may comple- 
ment functions lost in the mutants. However, retention of 
these genes in the type-specific region may indicate that part 
of their function cannot be duplicated by the second enzymes. 
Possibly,  this function is  the ability to be regulated under 
specific conditions, such as those that might be encountered 
during infection. The large noncoding region upstream of 
cps3U might be a site of regulation. An alternative explana- 
tion is that these genes were obtained along with the type- 
specific genes in a horizontal transfer from another organism 
and have not been lost.  This theory is consistent with hy- 
bridization data indicating that none of the type 3-specific 
genes could be detected in strains of six other pneumococcal 
types, including types with related capsule structures (13). 
However, if these genes serve no necessary function, it is sur- 
prising that they have been maintained in the type 3 cassettes 
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ception-binary encapsulation.  At low frequency, strains  of 
certain types transformed with DNA from strains of certain 
other types were found to produce both polysaccharides (12). 
Stable binary strains contained the second set of type-specific 
genes at a site unlinked to the recipient's type-specific genes. 
Once integrated,  these genes could not be moved to the normal 
location in a strain of heterologous type. These observations 
led Bernheimer et al. to suggest that recombination involved 
strong homology at only one end (49, 50). Unstable binary 
strains frequently lost the donor type-specific genes, which 
were usually linked to the recipient type-specific genes (49, 51). 
A. Cassette-type recombination 
v/peX 
a  r .............. 
-<~-~--4~o  -.  tyl~e X 
I 
Figure  8.  Repeated element. (/t) Ethidium bromide-stained agarose gel 
and (B) Southern  blot of S. pneumoniae chromosomal  DNA from seven 
different serotypes digested with HindllI, The blot was probed with the 
1.8-kb fragment  containing the region from the Sacl site upstream  of the 
type-specific genes to just before the Pvull site in c!os3D (bp 1 to 1802). 
Identical results were obtained  using pJD392 (containing bp 1 to 610) as 
the probe. 
of multiple  strains;  i.e.,  the restriction  maps  of the type 3 
regions of five non-clonal  strains are identical,  and all have 
cps3U and cps3M  (our unpublished  data). 
There are three requirements for a DNA region to be con- 
sidered a gene cassette:  (a)  more than  one copy of a gene 
or set of genes must exist,  each specifying the production 
of a different,  but related,  product;  (b) each copy must be 
flanked by DNA that  is common to all the copies; and (c) 
cassettes must recombine to cause replacement  of one copy 
by another. There is strong evidence to indicate that the type- 
specific  genes are arranged  as a cassette.  First,  the presence 
of more  than  80  different  serotypes implies  that  as  many 
different  sets of genes exist.  Second,  the type 2,  3,  5,  and 
6B type-specific genes are flanked to the right by a fragment 
common to  apparently  all  types,  and containing plfd. Al- 
though  the left flanking region from type 3 is common to 
all capsule types we have examined, it may not flank the type- 
specific genes in other types. If not,  then presumably other 
common DNA is located further upstream  of these genes. 
The third requirement  for a cassette is fulfilled by previous 
biochemical evidence (12) and our recent molecular evidence 
(13) demonstrating replacement of type-specific enzymes and 
genes, respectively,  following transformation of capsule type. 
Since the  proposal was put  forth  that  capsule genes are 
B. Binary encapsulation via homologous and illegitimate 
recombinations 
type X 
￿9  --o.-r  X_ ~_~,;._  "  typeZ 
C. Binary encapsulation via a transposition-like event 
type W 
O / 
-~o-.o  ~==~.-.  ~Z 
+ 
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Figure  9.  Models for the transfer of type-specific genes. (A) Cassette 
type-recombination. Replacement of the recipient's type-specific  genes with 
those of the donor results from homologous recombination between regions 
that flank the type-specific genes and  are common to all types.  O, 
sequence containing  repeated element; I,  common DNA upstream of 
type-specific cassettes; [---'1, common DNA (indudingp2pA) downstream 
of type-specific cassettes. (B) Binary encapsulation  by recombination  in- 
volving homology at only one end.  Homologous recombination  at one 
end of the type-specific cassette would occur  through the repeated  ele- 
ment. Integration at the other end would result from an apparent illegiti- 
mate recombination.  Linkage of the two type-specific cassettes would re- 
sult if the integration occurred  in a repeat element  in or closely linked 
to the recipient's capsule genes. (C) Binary encapsulation via a transposition- 
like event. Type-specific cassettes flanked by the repeated element  would 
resolve out of the chromosome and be transferred to recipient cells as cir- 
cular intermediates. Recombination into the recipient chromosome could 
occur at a repeat element unlinked  (as shown) or linked to the recipient's 
type-specific genes. Transfer of linear DNA could also yield binary strains 
as a result  of recombination  with two repeats that are closely linked in 
the recipient  chromosome. 
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concerning binary encapsulation (14, 49-51), we can propose 
models for capsule type change and binary capsule forma- 
tion. Cassette-type recombination would result from cross- 
over events in the homologous flanking regions, leading to 
replacement of the type-specific genes (Fig. 9 A). Binary en- 
capsulation may be mediated through the repeated element 
identified upstream of the type 3 capsule genes. Linkage analysis 
showed that  at least one copy of the repeat is unlinked  to 
the type 2 and 6B type-specific genes.  In type 3, one copy 
is linked but, based on transformation experiments, another 
is not (our unpublished observation). The mechanism pro- 
posed by Bernheimer et al. for stable binary strains could in- 
volve homologous recombination at a repeat element unlinked 
to the capsule locus; the recombination at the other end of 
the capsule genes would occur by an apparent  illegitimate 
recombination  event  (Fig.  9 B).  An alternative  possibility 
involves a transposition-like event that could result if certain 
type-specific genes are flanked on both sides by the repeat 
element (Fig. 9 C). Unstable binary strains could result from 
either type of integration occurring at repeated elements in, 
or closely linked to, the recipient's type-specific genes. Insta- 
bility could result from recombination through genes common 
to both capsule types, as suggested by Bernheimer et al., for 
the UDP-Glc DH of types 1 and 3. Our present results pro- 
vide the basis for examining these possibilities.  Binary strains 
containing the two sets of genes linked are of particular in- 
terest since they might  recombine to form a novel capsule 
type. Examination of strains producing related capsule struc- 
tures may help elucidate the possible mechanisms involved 
in novel capsule type formation. 
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